Malattia renale policistica
Ultimo aggiornamento 16 Dic 2024
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Polycystic kidney disease is a disorder that affects the kidneys and other organs. Clusters of fluid-filled sacs, called cysts, develop in the kidneys and interfere with their ability to filter waste products from the blood. The growth of cysts causes the kidneys to become enlarged and can lead to kidney failure. Cysts may also develop in other organs, particularly the liver.
Scelte video per Condizioni geneticheVideo library
Descrizione
Polycystic kidney disease is a disorder that affects the kidneys and other organs. Clusters of fluid-filled sacs, called cysts, develop in the kidneys and interfere with their ability to filter waste products from the blood. The growth of cysts causes the kidneys to become enlarged and can lead to kidney failure. Cysts may also develop in other organs, particularly the liver.
Frequent complications of polycystic kidney disease include dangerously high blood pressure (hypertension), pain in the back or sides, blood in the urine (hematuria), recurrent urinary tract infections, kidney stones, and heart valve abnormalities. Additionally, people with polycystic kidney disease have an increased risk of an abnormal bulging (an aneurysm) in a large blood vessel called the aorta or in blood vessels at the base of the brain. Aneurysms can be life-threatening if they tear or rupture.
The two major forms of polycystic kidney disease are distinguished by the usual age of onset and the pattern in which it is passed through families. The autosomal dominant form (sometimes called ADPKD) has signs and symptoms that typically begin in adulthood, although cysts in the kidney are often present from birth or childhood. Autosomal dominant polycystic kidney disease can be further divided into type 1 and type 2, depending on the genetic cause. The autosomal recessive form of polycystic kidney disease (sometimes called ARPKD) is much rarer and is often lethal early in life. The signs and symptoms of this condition are usually apparent at birth or in early infancy.
Modelli di ereditarietà
The source lists the following possible inheritance patterns: Autosomal dominant; Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Altri nomi
PKD
Polycystic renal disease
Related patient information and medicines

Patient information leaflet
Malattia renale policistica
Malattia renale policistica (PKD) causes many fluid-filled sacs (cysts) to develop in the kidneys. The most common type of PKD è an inherited condition called autosomal dominant polycystic kidney disease (ADPKD). L two common problems that develop are high blood pressure High blood pressure and chronic kidney disease (CKD) Chronic kidney disease..

Patient information leaflet
Malattia renale cronica
Chronic kidney disease means that the kidneys are not working as well as would be expected. Narrowing of the artery taking blood to the kidney (renal artery stenosis) Polycystic kidney disease. See the separate leaflet called Polycystic Kidney Disease Polycystic kidney disease. Blockages to the flow of urine, and repeated kidney infections..

Patient information leaflet
Infezione renale
A kidney infection (pyelonephritis) is an unpleasant illness which is sometimes serious. ... These complications are uncommon but may be more likely if: You become severely ill with the kidney infection. You already have a problem with your kidneys, such as polycystic kidney disease Polycystic kidney disease or chronic kidney disease Chronic.

Patient information leaflet
Diabete insipido
This seems to ... Persistently low levels of potassium in the blood. This has the same effect. Other medical conditions, such as sickle cell disease Sickle cell disease or polycystic kidney disease Polycystic kidney disease. Gestational diabetes insipidus This occurs in pregnant women, but is rare. When it does happen, it usually starts in the.

Patient information leaflet
Tasso di filtrazione glomerulare stimato
L estimated glomerular filtration rate (eGFR) does not diagnose any specific kidney disease but is a test to assess how well your kidneys are working. ...is commonly done as a routine part of monitoring people with kidney diseasesIn England and Wales, the National Institute for Health and Care Excellence (NICE) recommends the Chronic Kidney.

Patient information leaflet
Malattie cardiovascolari
Cardiovascular diseases (CVD) is a general term to describe diseases of the heart or blood vessels. The cause of most cardiovascular disease is a build-up of atheroma - a fatty deposit within the inside lining of arteries. Diabetes Diabetes. Chronic kidney disease Chronic kidney disease causing diminished kidney function. Fixed risk factors - ones.
Ulteriori letture e riferimenti
- Malattia renale policistica; MedlinePlus, National Library of Medicine.
- Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore). 2006 Jan;85(1):1-21. doi: 10.1097/01.md.0000200165.90373.9a.
- Boucher C, Sandford R. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur J Hum Genet. 2004 May;12(5):347-54. doi: 10.1038/sj.ejhg.5201162.
- Burgmaier K, Gimpel C, Schaefer F, Liebau M. Autosomal Recessive Polycystic Kidney Disease - PKHD1. 2001 Jul 19 [updated 2024 Apr 4]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1326/
- Eccles MR, Stayner CA. Polycystic kidney disease - where gene dosage counts. F1000Prime Rep. 2014 Apr 1;6:24. doi: 10.12703/P6-24. eCollection 2014.
- Harris PC, Torres VE. Polycystic Kidney Disease, Autosomal Dominant. 2002 Jan 10 [updated 2022 Sep 29]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1246/
- Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet. 1999 Jan 9;353(9147):103-7. doi: 10.1016/s0140-6736(98)03495-3.
- Horie S. ADPKD: molecular characterization and quest for treatment. Clin Exp Nephrol. 2005 Dec;9(4):282-291. doi: 10.1007/s10157-005-0367-6.
- Igarashi P, Somlo S. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002 Sep;13(9):2384-98. doi: 10.1097/01.asn.0000028643.17901.42. No abstract available.
- Lina F, Satlinb LM. Polycystic kidney disease: the cilium as a common pathway in cystogenesis. Curr Opin Pediatr. 2004 Apr;16(2):171-6. doi: 10.1097/00008480-200404000-00010.
- Sweeney WE Jr, Avner ED. Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. Pediatr Res. 2014 Jan;75(1-2):148-57. doi: 10.1038/pr.2013.191. Epub 2013 Oct 31.
- Tahvanainen E, Tahvanainen P, Kaariainen H, Hockerstedt K. Polycystic liver and kidney diseases. Ann Med. 2005;37(8):546-55. doi: 10.1080/07853890500389181.
- Wilson PD. Polycystic kidney disease. N Engl J Med. 2004 Jan 8;350(2):151-64. doi: 10.1056/NEJMra022161. No abstract available.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

